Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression

Psychiatry Research

Volumn 225, Issue 1-2, 2015, Pages 187-190

  Tsuchimine, Shoko ^a   Saito, Manabu ^a   Kaneko, Sunao ^a   Yasui Furukori, Norio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

AA; BDNF; Depression; DHA; EPA; Folate

Indexed keywords

ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; FOLIC ACID; BIOLOGICAL MARKER; UNSATURATED FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FATTY ACID BLOOD LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; PARENT; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SCORING SYSTEM; BLOOD; DEPRESSIVE DISORDER; PREDICTIVE VALUE; PSYCHOLOGY; REFERENCE VALUE;

ADOLESCENT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; DEPRESSIVE DISORDER; FATTY ACIDS, UNSATURATED; FEMALE; FOLIC ACID; HUMANS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES;

EID: 84916624482     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.11.018     Document Type: Article

References (50)

1. Altar C.A. Neurotrophins and depression. Trends in Pharmacological Sciences 1999, 20:59-61.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Association, Washington DC. 4th ed.
3. Beck A.T., Steer R.A., Brown G.K. BDI-II, Beck Depression Inventory: Manual 1996, Harcourt Brace, Boston. 2nd ed.
4. Beydoun M.A., Shroff M.R., Beydoun H.A., Zonderman A.B. Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults. Psychosomatic Medicine 2010, 72:862-873.
5. Birleson P. Children's depression questionnaire. Journal of Child Psychology and Psychiatry 1981, 22:73-78.
6. Birmaher B., Ryan N.D., Williamson D.E., Brent D.A., Kaufman J. Childhood and adolescent depression: a review of the past 10 years. Part II. Journal of the American Academy of Child & Adolescent Psychiatry 1996, 35:1575-1584.
7. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Nielsen M.G., Placentino A., Giovannini C., Rillosi L., Ventriglia M., Riva M.A., Gennarelli M. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World Journal of Biological Psychiatry 2010, 11:763-773.
8. Bottiglieri T. Homocysteine and folate metabolism in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005, 29:1103-1112.
9. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology 2008, 11:1169-1181.
10. Crowe F.L., Skeaff C.M., Green T.J., Gray A.R. Serum phospholipid n 3 long-chain polyunsaturated fatty acids and physical and mental health in a population-based survey of New Zealand adolescents and adults. American Journal of Clinical Nutrition 2007, 86:1278-1285.
11. Danese A., Moffitt T.E., Pariante C.M., Ambler A., Poulton R., Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry 2008, 65:409-416.
12. Das U.N. Long-chain polyunsaturated fatty acids in memory formation and consolidation: further evidence and discussion. Nutrition 2003, 19:988-994.
13. De la Presa Owens S., Innis S.M. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. Journal of Nutrition 1999, 129:2088-2093.
14. De Vriese S.R., Christophe A.B., Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sciences 2003, 73:3181-3187.
15. Dinan T., Siggins L., Scully P., O'Brien S., Ross P., Stanton C. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. Journal of Psychiatric Research 2009, 43:471-476.
16. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54:597-607.
17. Edwards R., Peet M., Shay J., Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders 1998, 48:149-156.
18. Ellis F.R., Sanders T.A. Long chain polyunsaturated fatty acids in endogenous depression. Journal of Neurology, Neurosurgery & Psychiatry 1977, 40:168-169.
19. Fehily A.M., Bowey O.A., Ellis F.R., Meade B.W., Dickerson J.W. Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochemistry International 1981, 3:37-42.
20. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck P.E., Marangell L.B., Richardson A.J., Lake J., Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 2006, 67:1954-1968.
21. Fulkerson J.A., Sherwood N.E., Perry C.L., Neumark-Sztainer D., Story M. Depressive symptoms and adolescent eating and health behaviors: a multifaceted view in a population-based sample. Preventive Medicine 2004, 38:865-875.
22. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research Reviews 2004, 45:104-115.
23. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 2010, 64:341-358.
24. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. British Journal of Psychiatry 2008, 192:268-274.
25. Lang U.E., Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cellular Physiology and Biochemistry 2013, 31:761-777. 10.1159/000350095.
26. Lerner V., Kanevsky M., Dwolatzky T., Rouach T., Kamin R., Miodownik C. Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clinical Nutrition 2006, 25:60-67.
27. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research 1999, 85:275-292.
28. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 4 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders 1996, 38:35-46.
29. Mamalakis G., Tornaritis M., Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukotriene Essential Fatty Acids 2002, 67:311-318.
30. Mamalakis G., Kiriakakis M., Tsibinos G., Kafatos A. Depression and adipose polyunsaturated fatty acids in an adolescent group. Prostaglandins Leukotriene Essential Fatty Acids 2004, 71:289-295.
31. Mamalakis G., Tornaritis M., Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukotriene Essential Fatty Acids 2002, 67:311-319.
32. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nature Neuroscience 2007, 10:1089-1094.
33. Molendijk M.L., Bus B.A., Spinhoven P., Penninx B.W., Kenis G., Prickaerts J., Voshaar R.C., Elzinga B.M. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Molecular Psychiatry 2011, 16:1088-1095.
34. Morris M.S., Fava M., Jacques P.F., Selhub J., Rosenberg I.H. Depression and folate status in the US population. Psychotherapy and Psychosomatics 2003, 72:80-87.
35. Murakami K., Miyake Y., Sasaki S., Tanaka K., Arakawa M. Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study. Psychosomatic Medicine 2010, 72:763-768.
36. Nanri A., Hayabuchi H., Ohta M., Sato M., Mishima N., Mizoue T. Serum folate and depressive symptoms among Japanese men and women: a cross-sectional and prospective study. Psychiatry Research 2012, 200:349-353.
37. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., Zalcman S. Preclinical models: status of basic research in depression. Biological Psychiatry 2002, 52:503-529.
38. Pallavi P., Sagar R., Mehta M., Sharma S., Subramanium A., Shamshi F., Sengupta U., Qadri R., Pandey R.M., Mukhopadhyay A.K. Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. Journal of Affective Disorders 2013, 150:415-423.
39. Penninx B.W., Guralnik J.M., Ferrucci L., Fried L.P., Allen R.H., Stabler S.P. Vitamin B (12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. American Journal of Psychiatry 2000, 157:715-721.
40. Pottala J.V., Talley J.A., Churchill S.W., Lynch D.A., von Schacky C., Harris W.S. Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukotriene Essential Fatty Acids 2012, 86:161-165.
41. Rao T.S., Asha M.R., Ramesh B.N., Rao K.S. Understanding nutrition, depression and mental illnesses. Indian Journal of Psychiatry 2008, 50:77-82.
42. Riemer S., Maes M., Christophe A., Rief W. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. Journal of Affective Disorders 2010, 123:173-180.
43. Sasaki T., Niitsu T., Hashimoto T., Kanahara N., Shiina A., Hasegawa T., Kimura H., Ishioka M., Tone J., Yamauchi A., Nakazato M., Hashimoto K., Iyo M. Decreased levels of serum brain derived neurotrophic factor in male pediatric patients with depression. Open Clinical Chemistry Journal 2011, 4:28-33.
44. Scharfman H.E., Maclusky N.J. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?. Trends in Neurosciences 2005, 28:79-85.
45. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008, 64:527-533.
46. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 2003, 54:70-75.
47. Su K.P., Huang S.Y., Chiu C.C., Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology 2003, 13:267-272.
48. Tiemeier H., van Tuijl H.R., Hofman A., Meijer J., Kiliaan A.J., Breteler M.M. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Amerian Journal of Psychiatry 2002, 159:2099-2101.
49. Weissman M.M., Wolk S., Goldstein R.B., Moreau D., Adams P., Greenwald S., Klier C.M., Ryan N.D., Dahl R.E., Wickramaratne P. Depressed adolescents grown up. Journal of the American Medical Association 1999, 281:1707-1714.
50. Yoshida T., Ishikawa M., Niitsu T., Nakazato M., Watanabe H., Shiraishi T., Shiina A., Hashimoto T., Kanahara N., Hasegawa T., Enohara M., Kimura A., Iyo M., Hashimoto K. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 2012, 7:e42676. 10.1371/journal.pone.0042676.